Drawing for EFESA

USPTO serial 79391354

EFESA

Reviewed by CopyMark Law Group

Reg. 7709057Status 700Registered
Filing date
Status date
Registration date
Mar 4, 2025
Examiner
FLETCHER, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EFESA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia A Wilczynski Brozek

Patricia A Wilczynski Brozek POKALSKY WILCZYNSKI BROZEK LLP40 Preston St., P.O. Box 1830Huntington, NY 11743United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment being pharmaceutical preparations for the treatment of dizziness; biological preparations for medical purposes being biological preparations for the treatment of anemia, kidney disease and kidney disorders; cardiovascular agents for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; synthetic peptides for pharmaceutical purposes being synthetic peptides for the treatment of anemia, kidney disease and kidney disorders; pharmaceuticals being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; medicines for human purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; anemia treatment medicines that stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; medicines to stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; pharmaceutical preparations for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes being biological preparations for the treatment of anemia; synthetic peptides for pharmaceutical and anemia treatment purposes being synthetic peptides for the treatment of anemia; synthetic peptides for pharmaceutical and kidney disease treatment purposes being synthetic peptides for the treatment of kidney diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 19, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 19, 2025FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 13, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 13, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 5, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 14, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 19, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 19, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 22, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 22, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 22, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 8, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 8, 2024RFRRREFUSAL PROCESSED BY MPU—
Jul 24, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 23, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2024DOCKASSIGNED TO EXAMINER—
Apr 24, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 22, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance